These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1709847)

  • 21. Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats.
    Giustina A; Misitano V; Voltz D; Piering A; Wehrenberg WB
    Endocr Res; 1995 Nov; 21(4):719-32. PubMed ID: 8582323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of pre-treatment with pyridostigmine on the stimulation of growth hormone by clonidine and GRF].
    Farello G; De Simone M; Gentile T; de Matteis F
    Minerva Pediatr; 1991 Oct; 43(10):617-20. PubMed ID: 1758382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects.
    Valcavi R; Zini M; Davoli S; Portioli I
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):360-4. PubMed ID: 1483293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone response to overnight growth hormone-releasing hormone infusion and oral pyridostigmine in children with short stature.
    Ross RJ; Savage MO; Kirk JM; Besser GM
    Acta Paediatr Scand Suppl; 1989; 349():114-6; discussion 123-4. PubMed ID: 2501967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA; DeMott-Friberg R; Barkan AL
    J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
    Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats.
    Arce V; García Barros M; Vara E; Lima L; Tresguerres JA; Devesa J
    Neuroendocrinology; 1995 May; 61(5):552-8. PubMed ID: 7617133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
    Borges MH; Castro RC; Kater CE; Lengyel AM
    Braz J Med Biol Res; 1993 Nov; 26(11):1191-200. PubMed ID: 7907904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children.
    Ghigo E; Goffi S; Mazza E; Imperiale E; Arvat E; Bellone J; Procopio M; Müller EE; Camanni F
    J Endocrinol Invest; 1989 Feb; 12(2):99-101. PubMed ID: 2754188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
    J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
    Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
    Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology.
    Dammacco F; Boghen MF; Camanni F; Cappa M; Ferrari C; Ghigo E; Giordano G; Loche S; Minuto F; Mucci M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):68-72. PubMed ID: 8325962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia.
    Murialdo G; Zerbi F; Filippi U; Tosca P; Fonzi S; Di Paolo E; Costelli P; Porro S; Polleri A; Savoldi F
    Neuropsychobiology; 1990-1991; 24(3):129-34. PubMed ID: 1983729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the cholinergic pathway in growth hormone feedback.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
    Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.